Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

59 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
C-X-C motif chemokine receptor 4-directed PET signal in the arterial tree is not consistently linked to calcified plaque burden and cardiovascular risk.
Kosmala A, Hasenauer N, Serfling SE, Michalski K, Fröhlich M, Dreher N, Hartrampf PE, Higuchi T, Buck AK, Weich A, Reiter T, Werner RA. Kosmala A, et al. Among authors: hartrampf pe. Theranostics. 2025 Jan 1;15(3):804-814. doi: 10.7150/thno.102910. eCollection 2025. Theranostics. 2025. PMID: 39776816 Free PMC article.
Predictive value of C-X-C motif chemokine receptor 4-directed molecular imaging in patients with advanced adrenocortical carcinoma.
Schloetelburg W, Hartrampf PE, Kosmala A, Serfling SE, Dreher N, Schirbel A, Fassnacht M, Buck AK, Werner RA, Hahner S. Schloetelburg W, et al. Among authors: hartrampf pe. Eur J Nucl Med Mol Imaging. 2024 Oct;51(12):3643-3650. doi: 10.1007/s00259-024-06800-z. Epub 2024 Jun 19. Eur J Nucl Med Mol Imaging. 2024. PMID: 38896128 Free PMC article.
Prognostic role of quantitative [18F]FDG PET/CT parameters in adrenocortical carcinoma.
Schlötelburg W, Hartrampf PE, Kosmala A, Fuss CT, Serfling SE, Buck AK, Schirbel A, Kircher S, Hahner S, Werner RA, Fassnacht M. Schlötelburg W, et al. Among authors: hartrampf pe. Endocrine. 2024 Jun;84(3):1172-1181. doi: 10.1007/s12020-024-03695-6. Epub 2024 Feb 21. Endocrine. 2024. PMID: 38381353 Free PMC article.
Radiopharmaceuticals for Treatment of Adrenocortical Carcinoma.
Michalski K, Schlötelburg W, Hartrampf PE, Kosmala A, Buck AK, Hahner S, Schirbel A. Michalski K, et al. Among authors: hartrampf pe. Pharmaceuticals (Basel). 2023 Dec 23;17(1):25. doi: 10.3390/ph17010025. Pharmaceuticals (Basel). 2023. PMID: 38256859 Free PMC article. Review.
Reply to Madhur Anand, Bela Jain, and Swati Aggarwal's Letter to the Editor re: Rudolf A. Werner, Philipp E. Hartrampf, Wolfgang P. Fendler, et al. Prostate-Specific Membrane Antigen Reporting and Data System Version 2.0. Eur Urol 2023;84:491-502.
Hartrampf PE, Rowe SP, Pomper MG, Higuchi T, Gorin MA, Werner RA. Hartrampf PE, et al. Eur Urol. 2024 May;85(5):e146-e147. doi: 10.1016/j.eururo.2023.11.023. Epub 2023 Dec 11. Eur Urol. 2024. PMID: 38087733 No abstract available.
CXCR4-directed PET/CT with [68 Ga]Ga-pentixafor in solid tumors-a comprehensive analysis of imaging findings and comparison with histopathology.
Dreher N, Hahner S, Fuß CT, Schlötelburg W, Hartrampf PE, Serfling SE, Schirbel A, Samnick S, Higuchi T, Weich A, Lapa C, Rosenwald A, Buck AK, Kircher S, Werner RA. Dreher N, et al. Among authors: hartrampf pe. Eur J Nucl Med Mol Imaging. 2024 Apr;51(5):1383-1394. doi: 10.1007/s00259-023-06547-z. Epub 2023 Dec 12. Eur J Nucl Med Mol Imaging. 2024. PMID: 38082196 Free PMC article.
59 results